FDA Gives OK to Merck Antiviral At - Home COVID - 19 Pill
Molnupiravir cut the risk for hospitalization and death in high - risk patients by 30 percent
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Infections, Internal Medicine, Emergency Medicine, Nursing, Pharmacy, Pulmonology, FDA Approvals, Source Type: news
More News: COVID-19 | Emergency Medicine | Geriatrics | Internal Medicine | Merck | Nurses | Nursing | Respiratory Medicine